- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 209/04 - IndolesHydrogenated indoles
Patent holdings for IPC class C07D 209/04
Total number of patents in this class: 594
10-year publication summary
|
39
|
31
|
33
|
22
|
34
|
26
|
23
|
36
|
30
|
22
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Katholieke Universiteit Leuven | 1194 |
11 |
| Janssen Pharmaceuticals, Inc. | 430 |
10 |
| Boehringer Ingelheim International GmbH | 4642 |
9 |
| Caamtech, Inc. | 144 |
8 |
| Bristol-myers Squibb Company | 4880 |
7 |
| Vertex Pharmaceuticals Incorporated | 1600 |
7 |
| The Scripps Research Institute | 1346 |
7 |
| The Regents of the University of California | 19961 |
6 |
| The General Hospital Corporation | 4740 |
6 |
| Merck Sharp & Dohme LLC | 3751 |
6 |
| LG Chem, Ltd. | 17635 |
5 |
| Board of Regents, The University of Texas System | 5808 |
5 |
| Korea Institute of Science and Technology | 2123 |
5 |
| Nanoquantum Sciences, Inc. | 6 |
5 |
| Vanderbilt University | 1907 |
5 |
| Kuleon LLC | 17 |
5 |
| The Trustees of the University of Pennsylvania | 4323 |
4 |
| Akaal Pharma Pty Ltd. | 11 |
4 |
| AnaSpec Incorporated | 27 |
4 |
| Council of Scientific & Industrial Research | 1427 |
4 |
| Other owners | 471 |